Joe Papa

Production lines for new lenses will create 100 jobs over the next four years

Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013

Dublin-based drugmaker was urged last year to explore a sale of its prescription business

Announcement by Canadian pharmaceutical company drives its shares up by 13%

Dutch-domiciled US group says it is still fully committed to planned $7.2bn takeover of Sweden’s Meda

What Papa brings to the party is a depth of experience from over 30 years in the business

Dublin-based drugmaker’s chief executive Joe Papa receives additional stock and bonus

CEO Joe Papa and CFOJudy Brown hope to persuade Israeli holders of 10% of company not to accept takeover offer

Offer from Mylan remains valid and capable of acceptance by Perrigo shareholders

Irish pharma company claims Mylan’s $27bn offer overstates potential synergies and makes false claims

Company’s shareholders vote to move forward with mega-merger of pharma groups

Bolt-on acqusition strengthens position in Europe amid three-way takeover battle

Perrigo chief executive Joe Papa and Mylan chairman Robert Coury talking about merger for some time

Company does deal with partner Transition Therapeutics as it separately spends $51m on over-the-counter products in Australia